Aug 7th, 2024
Novo Nordisk Lowers Annual Profit Forecast
Novo Nordisk said full-year operating profit will grow 20% to 28%, down slightly from its earlier forecast. Second-quarter sales of weight-loss treatment Wegovy were 11.7 billion Danish kroner ($1.7 billion), the Danish company said in a statement Wednesday, while the average estimate was 13.7 billion kroner. Bloomberg's Sanne Wass reports.
